Kite Phar­ma gets FDA to sign off on new Cal­i­for­nia-based vec­tor man­u­fac­tur­ing fa­cil­i­ty

Kite Phar­ma just got FDA ap­proval to kick off op­er­a­tions at a new man­u­fac­tur­ing cam­pus.

The can­cer-fo­cused, CAR-T cell ther­a­py play­er made the an­nounce­ment Mon­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER